Melanoma vaccine treatment cut risk of recurrence or death by 58% but failed to exceed Wall Street’s lofty expectations

Excerpt from Financial Times. Original publication ↗

Source: Financial Times

At a glance

Topic
Health
Country
🇬🇧 GB
Publisher language
EN
Added to Allnira